BAX (BCL2-associated X protein) is a pro‑apoptotic member of the Bcl‑2 protein family that regulates the intrinsic (mitochondrial) pathway of programmed cell death. It is encoded by the human BAX gene located on chromosome 19p13.3 and is expressed in a wide variety of tissues.
Structure
BAX consists of 192 amino acids and contains the characteristic Bcl‑2 homology (BH) domains BH1, BH2, BH3, and a C‑terminal transmembrane helix. In its inactive state, BAX is primarily cytosolic and adopts a compact conformation in which the BH3 domain is sequestered. Upon activation, conformational changes expose the BH3 domain and the C‑terminal helix, allowing insertion into the mitochondrial outer membrane.
Mechanism of Action
Activation of BAX is triggered by various cellular stresses, including DNA damage, cytokine deprivation, and oncogenic signals. Pro‑apoptotic BH3‑only proteins such as BID, BIM, and PUMA bind to BAX’s hydrophobic groove, promoting its oligomerization. Oligomerized BAX inserts into the mitochondrial outer membrane, forming pores that facilitate the release of cytochrome c and other apoptogenic factors into the cytosol. This initiates the caspase cascade leading to cellular demolition.
Regulation
- Transcriptional control: p53, c‑Myc, and other transcription factors can up‑regulate BAX expression in response to stress.
- Post‑translational modifications: Phosphorylation, ubiquitination, and proteolytic cleavage modulate BAX stability and activity.
- Protein‑protein interactions: Anti‑apoptotic Bcl‑2 family members (e.g., BCL‑2, BCL‑XL, MCL‑1) bind and sequester BAX, preventing its oligomerization. Conversely, BH3‑only proteins act as activators or sensitizers that relieve this inhibition.
Physiological Role
BAX is essential for normal apoptosis during development, immune regulation, and tissue homeostasis. Genetic ablation of BAX in mice results in reduced apoptosis, leading to lymphoid hyperplasia and resistance to certain apoptotic stimuli, demonstrating its non‑redundant pro‑apoptotic function.
Pathological Significance
- Cancer: Down‑regulation or functional inactivation of BAX contributes to tumorigenesis by allowing cells to evade apoptosis. Mutations in the BAX gene have been identified in hematologic malignancies, colorectal carcinoma, and other cancers.
- Neurodegeneration: Excessive BAX activation is implicated in neuronal loss in conditions such as Alzheimer’s disease, Parkinson’s disease, and ischemic stroke.
- Therapeutic targeting: Small‑molecule BH3 mimetics (e.g., ABT‑737, venetoclax) indirectly engage BAX by displacing it from anti‑apoptotic Bcl‑2 proteins, thereby restoring apoptotic signaling in cancer cells.
Research Tools
Antibodies specific to the activated conformation of BAX, genetically engineered BAX‑knockout cell lines, and fluorescent reporters of mitochondrial outer‑membrane permeabilization are commonly employed to study BAX function.
References
- Oltvai, Z.N., Milliman, C.L., Korsmeyer, S.J. (1993). BAX, a novel member of the Bcl‑2 family, promotes apoptosis. Cell, 74(4), 727‑738.
- Wang, X., et al. (2000). Structure of BAX and its activation by BH3 domains. Nature, 403, 332‑337.
- Shulga, N., et al. (2019). Regulation of BAX in apoptosis and disease. Trends in Cell Biology, 29(4), 311‑322.